Ontology highlight
ABSTRACT:
SUBMITTER: Monami M
PROVIDER: S-EPMC3362858 | biostudies-other | 2012
REPOSITORIES: biostudies-other
Experimental diabetes research 20120520
Glucagon-Like Peptide-1 receptor agonists (GLP-1RAs), approved as glucose-lowering drugs for the treatment of type 2 diabetes, have also been shown to reduce body weight. An extensive Medline, Cochrane database, and Embase search for "exenatide," "liraglutide," "albiglutide," "semaglutide," and "lixisenatide" was performed, collecting all randomized clinical trials on humans up to December 15, 2011, with a duration of at least 24 weeks, comparing GLP-1 receptor agonists with either placebo or ac ...[more]